目的:探讨多学科围术期疼痛干预对胸腔镜肺叶切除术(VATS)术后疼痛、术后恢复和并发症的影响。方法:选取施行VATS治疗的116例患者为研究对象。依据干预方式不同将116例VATS患者分为对照组和观察组,每组各58例。对照组实施常规疼痛干预;...目的:探讨多学科围术期疼痛干预对胸腔镜肺叶切除术(VATS)术后疼痛、术后恢复和并发症的影响。方法:选取施行VATS治疗的116例患者为研究对象。依据干预方式不同将116例VATS患者分为对照组和观察组,每组各58例。对照组实施常规疼痛干预;观察组实施多学科围术期疼痛干预。比较两组疼痛情况[数字疼痛评分法(NRS)]、术后恢复情况、术后康复质量[Quality of Recovery-15,QoR-15]及并发症发生情况。结果:术后24 h及术后72 h观察组静息及咳嗽时NRS评分均低于对照组(P<0.05)。观察组术后首次下床活动时间、首次排气时间、首次经口进食时间及术后住院时间均短于对照组(P<0.05)。术后72 h,两组QoR-15评分均高于术后24 h(P<0.05),且观察组术后24、72 h QoR-15评分均高于对照组(P<0.05)。观察组总并发症发生率低于对照组(8.61%vs.22.41%,P<0.05)。结论:多学科围术期疼痛干预可降低VATS术后疼痛,促进术后恢复进程,提升康复质量,并能在一定程度上减少并发症发生。展开更多
BACKGROUND Pulmonary mucoepidermoid carcinoma(PMEC)is a rare malignancy that arises from minor salivary glands within the tracheobronchial tree.The clear cell variant of PMEC is exceptionally uncommon and presents not...BACKGROUND Pulmonary mucoepidermoid carcinoma(PMEC)is a rare malignancy that arises from minor salivary glands within the tracheobronchial tree.The clear cell variant of PMEC is exceptionally uncommon and presents notable diagnostic challenges,primarily attributable to its morphological similarity to other tumors containing clear cells.CASE SUMMARY A 22-year-old male,formerly in good health,came in with a two-month duration of persistent cough and production of sputum.Subsequent imaging and bronchoscopy examinations revealed a 2 cm tumor in the distal left main bronchus,which resulted in complete atelectasis of the left lung.Further assessment via positron emission tomography/computed tomography scans and endoscopic biopsy confirmed the primary malignant nature of the tumor,charac-terized by clear cell morphology in most of the tumor cells.The patient underwent a left lower lobe sleeve resection accompanied by systematic mediastinal lymph node dissection.Molecular pathology analysis subsequently revealed a CRTC3-MAML2 gene fusion,leading to a definitive pathological diagnosis of the clear cell variant of PMEC,staged as T2N0M0.After surgery,the patient experienced a smooth recovery and exhibited no signs of recurrence during the one-and-a-half-year follow-up period.CONCLUSION This article describes an unusual case of a clear cell variant of PMEC characterized by the presence of a CRTC3-MAML2 gene fusion in a 22-year-old male.The patient underwent successful left lower lobe sleeve resection.This case underscores the distinctive challenges associated with diagnosing and treating this uncommon malignancy,underscoring the importance of precise diagnosis and personalized treatment strategies.展开更多
文摘目的:探讨多学科围术期疼痛干预对胸腔镜肺叶切除术(VATS)术后疼痛、术后恢复和并发症的影响。方法:选取施行VATS治疗的116例患者为研究对象。依据干预方式不同将116例VATS患者分为对照组和观察组,每组各58例。对照组实施常规疼痛干预;观察组实施多学科围术期疼痛干预。比较两组疼痛情况[数字疼痛评分法(NRS)]、术后恢复情况、术后康复质量[Quality of Recovery-15,QoR-15]及并发症发生情况。结果:术后24 h及术后72 h观察组静息及咳嗽时NRS评分均低于对照组(P<0.05)。观察组术后首次下床活动时间、首次排气时间、首次经口进食时间及术后住院时间均短于对照组(P<0.05)。术后72 h,两组QoR-15评分均高于术后24 h(P<0.05),且观察组术后24、72 h QoR-15评分均高于对照组(P<0.05)。观察组总并发症发生率低于对照组(8.61%vs.22.41%,P<0.05)。结论:多学科围术期疼痛干预可降低VATS术后疼痛,促进术后恢复进程,提升康复质量,并能在一定程度上减少并发症发生。
基金Hunan Provincial Natural Science Foundation of China,No.2022JJ40246The Hunan Cancer Hospital Climb Plan,No.2021NSFC-B005.
文摘BACKGROUND Pulmonary mucoepidermoid carcinoma(PMEC)is a rare malignancy that arises from minor salivary glands within the tracheobronchial tree.The clear cell variant of PMEC is exceptionally uncommon and presents notable diagnostic challenges,primarily attributable to its morphological similarity to other tumors containing clear cells.CASE SUMMARY A 22-year-old male,formerly in good health,came in with a two-month duration of persistent cough and production of sputum.Subsequent imaging and bronchoscopy examinations revealed a 2 cm tumor in the distal left main bronchus,which resulted in complete atelectasis of the left lung.Further assessment via positron emission tomography/computed tomography scans and endoscopic biopsy confirmed the primary malignant nature of the tumor,charac-terized by clear cell morphology in most of the tumor cells.The patient underwent a left lower lobe sleeve resection accompanied by systematic mediastinal lymph node dissection.Molecular pathology analysis subsequently revealed a CRTC3-MAML2 gene fusion,leading to a definitive pathological diagnosis of the clear cell variant of PMEC,staged as T2N0M0.After surgery,the patient experienced a smooth recovery and exhibited no signs of recurrence during the one-and-a-half-year follow-up period.CONCLUSION This article describes an unusual case of a clear cell variant of PMEC characterized by the presence of a CRTC3-MAML2 gene fusion in a 22-year-old male.The patient underwent successful left lower lobe sleeve resection.This case underscores the distinctive challenges associated with diagnosing and treating this uncommon malignancy,underscoring the importance of precise diagnosis and personalized treatment strategies.